Squarepoint Ops LLC Mei Pharma, Inc. Transaction History

Squarepoint Ops LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.65 $13,663 - $21,146	32,533 New	32,533 $20,000
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $22,308 - $113,194	-41,312 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $109,689 - $158,649	-47,077 Reduced 53.26%	41,312 $110,000
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $34,282 - $40,675	-13,604 Reduced 13.34%	88,389 $244,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $265,181 - $372,274	101,993 New	101,993 $291,000
Q1 2021 May 17, 2021	SELL	$2.73 - $4.5 $76,838 - $126,657	-28,146 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.6 - $3.32 $196,443 - $250,842	-75,555 Reduced 72.86%	28,146 $74,000
Q3 2020 Nov 16, 2020	BUY	$2.46 - $4.27 $151,727 - $263,365	61,678 Added 146.77%	103,701 $324,000
Q2 2020 Aug 14, 2020	SELL	$1.45 - $4.3 $49,996 - $148,264	-34,480 Reduced 45.07%	42,023 $174,000
Q1 2020 May 15, 2020	SELL	$0.75 - $2.55 $2,333 - $7,933	-3,111 Reduced 3.91%	76,503 $123,000
Q4 2019 Feb 14, 2020	BUY	$1.65 - $2.48 $131,363 - $197,442	79,614 New	79,614 $197,000
Q2 2018 Aug 14, 2018	SELL	$1.89 - $4.95 $23,625 - $61,875	-12,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.06 - $2.38 $25,750 - $29,750	12,500 New	12,500 $26,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.